LAIR-1 suppresses cell growth of ovarian cancer cell via the PI3K-AKT-mTOR pathway

Author:

Liu Yan12,Ma Li12,Shangguan Fugen32,Zhao Xuena4,Wang Wenjie4,Gao Zhiyue4,Zhou Huimin4,Qu Guiwu5,Huang Yumei6,An Jing7,Xue Jiangnan1,Yang Shude8,Cao Qizhi15

Affiliation:

1. Department of Immunology, School of Basic Medical Sciences, Binzhou Medical University, Yantai 264003, Shandong, P.R. China

2. Equal contribution

3. Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, P.R. China

4. Binzhou Medical University, Yantai 264003, Shandong, P.R. China

5. Anti-aging Research Institution, Binzhou Medical University, Yantai 264003, Shandong, P.R.China

6. Department of Stomatology, Affiliated Hospital of Binzhou Medical College, Binzhou 256603, Shandong, P.R. China

7. Division of Infectious Diseases and Global Health, School of Medicine, University of California at San Diego, La Jolla, CA 92037, USA

8. School of Agriculture, Ludong University, Yantai 264025, Shandong, P.R.China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Ageing

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3